🔎 Trials Near Me

Home › Infezioni virali › Maryland

Studi clinici su Infezioni virali nello stato di Maryland

14 studi su Infezioni virali cercano partecipanti presso sedi nello stato di Maryland.

Città nello stato di Maryland

Testo ufficiale dello studio (inglese)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Annapolis
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05624450

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

  • National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età da 18 a 120 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT00006518

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

  • National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età da 2 a 100 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT01011712

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Centennial Medical Group, Columbia
  • Jadestone Clinical Research, Silver Spring
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Johns Hopkins Hospital, Baltimore
  • Jadestone Clinical Research, Silver Spring
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07013474

Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

  • National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 50 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07706686

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

  • University of Maryland, Baltimore
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT07654283

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

  • National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 50 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT06863142

Viral Infections in Healthy and Immunocompromised Hosts

  • National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionaleVolontari sani benvenuti
6 Months – 120 Years · Tutti i sessi · Aggiornato il 14 set 2026 · NCT01306084

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

  • National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionaleVolontari sani benvenuti
2 Months – 115 Years · Tutti i sessi · Aggiornato il 10 set 2026 · NCT04419870

Genetic Studies of Chronic Active Epstein-Barr Disease

  • National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età da 1 a 120 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT00032513

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

  • Johns Hopkins, Baltimore
In reclutamentoFase 1/2
1 Month – 79 Years · Tutti i sessi · Aggiornato il 15 apr 2026 · NCT04197596

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

  • Johns Hopkins University, Baltimore
  • National Institutes of Health (NIH), Bethesda
In reclutamentoFase 1
3 Months – 80 Years · Tutti i sessi · Aggiornato il 26 gen 2026 · NCT04691622

Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

  • All Natural Medicine Clinic, LLC, Rockville
In reclutamentoFase 1/2
Tutte le età · Tutti i sessi · Aggiornato il 19 feb 2025 · NCT04790240

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.